Alnylam Pharmaceuticals (NQ: ALNY )

126.82 USD -1.85 (-1.44%)

Official Closing Price Updated: 7:57 PM EDT, Oct 27, 2020 Add to My Watchlist

Price and Volume

Volume	521,900
Open	128.52
Bid (Size)	126.00 (2)
Ask (Size)	131.33 (1)
Prev. Close	128.67
Today's Range	126.07 - 130.88
52wk Range	83.06 - 167.33
Shares Outstanding	100,522,411
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Alnylam to Webcast Conference Call Discussing Third Quarter 2020 Financial Results

October 22, 2020

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2020 on Thursday,...

Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxaluria Type 1 at the American Society of Nephrology Kidney Week

October 22, 2020

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today positive results from the 6-month primary analysis of the ILLUMINATE-B Phase 3 pediatric study of...

Performance

YTD	+9.69%	+9.69%
1 Month	-9.29%	-9.29%
3 Month	-17.83%	-17.83%
6 Month	-7.77%	-7.77%
1 Year	+40.69%	+40.69%

More News

Alnylam Receives Positive CHMP Opinion for OXLUMO™ (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups

October 16, 2020

Vir and Alnylam to Webcast Virtual Fireside Chat at H.C. Wainwright Hepatitis B Virus Mini-Conference

October 13, 2020

Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six

September 30, 2020

Alnylam to Webcast Presentation at Chardan Virtual 4th Annual Genetic Medicines Conference

September 28, 2020

Notable Monday Option Activity: AX, ALNY, GME

October 26, 2020

Alnylam Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ALNY

October 23, 2020

12 Healthcare Stocks Moving In Thursday's After-Market Session

October 22, 2020

RWDC's Underlying Holdings Could Mean 10% Gain Potential

October 15, 2020

9 Biotech Stocks With Material Catalysts In Q4

October 13, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.